Dana Inc/ US2358252052 /
6/4/2024 9:59:55 PM | Chg. -0.25 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
13.65USD | -1.80% | 32,110 Turnover: 440,175.31 |
-Bid Size: - | -Ask Size: - | 1.98 bill.USD | 2.93% | 52.46 |
GlobeNewswire
6/4
Verisk’s National Equipment Register (NER) and KYCS Global Collaborate to Enhance Heavy Equipment Se...
GlobeNewswire
6/2
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Acro...
GlobeNewswire
5/28
LiquidStack to Showcase Immersion Cooling Technology at Cisco Live's Sustainability Zone
GlobeNewswire
5/23
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...
GlobeNewswire
5/20
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponso...
GlobeNewswire
5/15
Pacific Software Inc. Secures Strategic License Agreement with the University of California for Inno...
GlobeNewswire
5/13
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire
5/10
Open Space Institute Holds 50th Anniversary Gala Honoring Founders John & Patricia Adams and Longtim...
GlobeNewswire
5/9
Konica Minolta’s Jason Dizzine and Dana Drury Named as ENX Magazine 2024 Difference Makers
GlobeNewswire
5/8
LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activatio...